Research projects
Start of main content
Personalized therapies in ovarian cancer to overcome resistance
Personalized therapy, immunotherapy and cancer
Senior Researcher : Sandra Muñoz Galván
Abstract
Ovarian cancer (OC) is the gynecological cancer with the highest mortality rate, largely due to high resistance to conventional therapies. Therefore, finding more effective treatments overcoming chemotherapy resistance is of vital importance and a priority in cancer research. OC is characterized by high rates of genome instability, which is likely caused by DNA repair defects, and is treated with platinum-based compounds, which are genotoxic agents, in the first line. Although new therapies targeting DNA repair, as poly-ADP ribose polymerase inhibitors, have improved patient outcomes in relevant phenotypes, many patients will not benefit from these therapies and therefore a better stratification is required. In this project, we will search for new DNA repair therapeutic targets that can overcome chemotherapy resistance in OC. The results of this project have the potential to aid in personalizing treatments of OC patients based on predictive molecular biomarkers, generating greater efficacy and less toxicity. Consequently, our project has a direct impact on the clinical management of OC patients and will contribute to improve the survival and quality of life of these women.
-
Activities related
-
Projects related
-
News related
-
Publications related
Activities related
-
26
Jun
2024
Conferencias La aventura de la ciencia Madrid, Miércoles 26 de junio de 2024, 19:00 horas
-
13
Feb
2025
17th edition. Cycle of conferences and debates in science Digital Twins: Technological Advances and Application Opportunities Madrid, Thursday, 13 February 2025, 17:30 hours
-
18
Feb
2025
Session New Therapies for the Inflammation Treatment Madrid, Feb 18th, 2025, Tuesday. 4PM
Projects related
- Renewable Ammonia as an Energy Vector 2022 Senior Researcher : Francisco Pelayo García Arquer Research Centre or Institution : Instituto de Ciencias Fotónicas, ICFO. Barcelona
- Programming bacterial metabolism for the valorization of plastic wastes (ProgStrain): 2022 Senior Researcher : Sergio Bordel Velasco Research Centre or Institution : Universidad de Valladolid
- Harnessing microRNAs for cancer immunotherapy 2022 Senior Researcher : Alicia González Martín Research Centre or Institution : Universidad Autónoma de Madrid.
News related
Publications related
End of main content